Selective effects of thiazide therapy on serum 1α,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias

J. E. Zerwekh, C. Y C Pak

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

The effect of long-term thiazide therapy (hydro-chlorothiazide, 50 mg twice/day) on intestinal calcium (Ca) absorption and serum 1α,25-dihydroxy-vitamin D [1α,25-(OH)2D] concentration was examined in 10 patients with renal hypercalciuria (RH), many of whom had hyperabsorption of Ca, and in 11 cases of absorptive hypercalciuria (AH), all of whom had intestinal hyperabsorption of Ca. In patients with RH, the intestinal Ca absorption decreased significantly during thiazide therapy (mean treatment period of 15 mo) from 0.68 ± 0.09 SD to 0.56 ± 0.10 (p < 0.01), commmensurate with the "correction" of the renal leak of Ca and secondary hyperparathyroidism. Furthermone, serum 1α,25-(OH)2D decreased significantly from 5.2 ± 2.2 SD ng/dl to 3.7 ± 0.8 ng/dl (p < 0.025) during thiazide therapy. In patiens with AH, the intestinal hyperabsorption of calcium persisted during thiazide treatment 0.69 ± 0.07 versus 0.69 ± 0.06), despite restoration of normal urinary Ca. Serum 1α,25-(OH)2D was virtually unchanged during treatment (4.5 ± 1.4 ng/dl versus 4.7 ± 0.9 ng/dl). The results support the hypothesis that the intestinal hyperabsorption of Ca in RH is a result of increased serum concentration of 1α,25-(OH)2D secondary to the hyperparathyroid state, while that in AH may not be totally dependent on increased concentrations of 1α,25-(OH)2D.

Original languageEnglish (US)
Pages (from-to)13-17
Number of pages5
JournalMetabolism
Volume29
Issue number1
DOIs
StatePublished - 1980

Fingerprint

Thiazides
Intestinal Absorption
Hypercalciuria
Calcium
Kidney
Serum
Therapeutics
Chlorothiazide
Secondary Hyperparathyroidism
1,25-dihydroxyvitamin D
Vitamin D

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

@article{658d5a5fce9345bd94502e267581b9e1,
title = "Selective effects of thiazide therapy on serum 1α,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias",
abstract = "The effect of long-term thiazide therapy (hydro-chlorothiazide, 50 mg twice/day) on intestinal calcium (Ca) absorption and serum 1α,25-dihydroxy-vitamin D [1α,25-(OH)2D] concentration was examined in 10 patients with renal hypercalciuria (RH), many of whom had hyperabsorption of Ca, and in 11 cases of absorptive hypercalciuria (AH), all of whom had intestinal hyperabsorption of Ca. In patients with RH, the intestinal Ca absorption decreased significantly during thiazide therapy (mean treatment period of 15 mo) from 0.68 ± 0.09 SD to 0.56 ± 0.10 (p < 0.01), commmensurate with the {"}correction{"} of the renal leak of Ca and secondary hyperparathyroidism. Furthermone, serum 1α,25-(OH)2D decreased significantly from 5.2 ± 2.2 SD ng/dl to 3.7 ± 0.8 ng/dl (p < 0.025) during thiazide therapy. In patiens with AH, the intestinal hyperabsorption of calcium persisted during thiazide treatment 0.69 ± 0.07 versus 0.69 ± 0.06), despite restoration of normal urinary Ca. Serum 1α,25-(OH)2D was virtually unchanged during treatment (4.5 ± 1.4 ng/dl versus 4.7 ± 0.9 ng/dl). The results support the hypothesis that the intestinal hyperabsorption of Ca in RH is a result of increased serum concentration of 1α,25-(OH)2D secondary to the hyperparathyroid state, while that in AH may not be totally dependent on increased concentrations of 1α,25-(OH)2D.",
author = "Zerwekh, {J. E.} and Pak, {C. Y C}",
year = "1980",
doi = "10.1016/0026-0495(80)90091-8",
language = "English (US)",
volume = "29",
pages = "13--17",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Selective effects of thiazide therapy on serum 1α,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias

AU - Zerwekh, J. E.

AU - Pak, C. Y C

PY - 1980

Y1 - 1980

N2 - The effect of long-term thiazide therapy (hydro-chlorothiazide, 50 mg twice/day) on intestinal calcium (Ca) absorption and serum 1α,25-dihydroxy-vitamin D [1α,25-(OH)2D] concentration was examined in 10 patients with renal hypercalciuria (RH), many of whom had hyperabsorption of Ca, and in 11 cases of absorptive hypercalciuria (AH), all of whom had intestinal hyperabsorption of Ca. In patients with RH, the intestinal Ca absorption decreased significantly during thiazide therapy (mean treatment period of 15 mo) from 0.68 ± 0.09 SD to 0.56 ± 0.10 (p < 0.01), commmensurate with the "correction" of the renal leak of Ca and secondary hyperparathyroidism. Furthermone, serum 1α,25-(OH)2D decreased significantly from 5.2 ± 2.2 SD ng/dl to 3.7 ± 0.8 ng/dl (p < 0.025) during thiazide therapy. In patiens with AH, the intestinal hyperabsorption of calcium persisted during thiazide treatment 0.69 ± 0.07 versus 0.69 ± 0.06), despite restoration of normal urinary Ca. Serum 1α,25-(OH)2D was virtually unchanged during treatment (4.5 ± 1.4 ng/dl versus 4.7 ± 0.9 ng/dl). The results support the hypothesis that the intestinal hyperabsorption of Ca in RH is a result of increased serum concentration of 1α,25-(OH)2D secondary to the hyperparathyroid state, while that in AH may not be totally dependent on increased concentrations of 1α,25-(OH)2D.

AB - The effect of long-term thiazide therapy (hydro-chlorothiazide, 50 mg twice/day) on intestinal calcium (Ca) absorption and serum 1α,25-dihydroxy-vitamin D [1α,25-(OH)2D] concentration was examined in 10 patients with renal hypercalciuria (RH), many of whom had hyperabsorption of Ca, and in 11 cases of absorptive hypercalciuria (AH), all of whom had intestinal hyperabsorption of Ca. In patients with RH, the intestinal Ca absorption decreased significantly during thiazide therapy (mean treatment period of 15 mo) from 0.68 ± 0.09 SD to 0.56 ± 0.10 (p < 0.01), commmensurate with the "correction" of the renal leak of Ca and secondary hyperparathyroidism. Furthermone, serum 1α,25-(OH)2D decreased significantly from 5.2 ± 2.2 SD ng/dl to 3.7 ± 0.8 ng/dl (p < 0.025) during thiazide therapy. In patiens with AH, the intestinal hyperabsorption of calcium persisted during thiazide treatment 0.69 ± 0.07 versus 0.69 ± 0.06), despite restoration of normal urinary Ca. Serum 1α,25-(OH)2D was virtually unchanged during treatment (4.5 ± 1.4 ng/dl versus 4.7 ± 0.9 ng/dl). The results support the hypothesis that the intestinal hyperabsorption of Ca in RH is a result of increased serum concentration of 1α,25-(OH)2D secondary to the hyperparathyroid state, while that in AH may not be totally dependent on increased concentrations of 1α,25-(OH)2D.

UR - http://www.scopus.com/inward/record.url?scp=0018917132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018917132&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(80)90091-8

DO - 10.1016/0026-0495(80)90091-8

M3 - Article

C2 - 7351872

AN - SCOPUS:0018917132

VL - 29

SP - 13

EP - 17

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 1

ER -